These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 17145817)
1. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962. Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI; Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817 [TBL] [Abstract][Full Text] [Related]
2. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study. Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME; J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887 [TBL] [Abstract][Full Text] [Related]
3. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717 [TBL] [Abstract][Full Text] [Related]
4. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF; Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527 [TBL] [Abstract][Full Text] [Related]
7. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. Nachman JB; Sather HN; Sensel MG; Trigg ME; Cherlow JM; Lukens JN; Wolff L; Uckun FM; Gaynon PS N Engl J Med; 1998 Jun; 338(23):1663-71. PubMed ID: 9614257 [TBL] [Abstract][Full Text] [Related]
8. [Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia]. Yang HQ; Zhang RH; Zhang ZH; Wan CC; Xia YJ Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):526-8. PubMed ID: 18082030 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914 [TBL] [Abstract][Full Text] [Related]
10. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920 [TBL] [Abstract][Full Text] [Related]
11. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607 [TBL] [Abstract][Full Text] [Related]
12. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. De Vita F; Orditura M; Lieto E; Infusino S; Morgillo F; Martinelli E; Castellano P; Romano C; Ciardiello F; Catalano G; Pignatelli C; Galizia G Cancer; 2004 Jan; 100(2):270-8. PubMed ID: 14716760 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Koomagi R; Zintl F; Sauerbrey A; Volm M Clin Cancer Res; 2001 Nov; 7(11):3381-4. PubMed ID: 11705851 [TBL] [Abstract][Full Text] [Related]
14. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954 [TBL] [Abstract][Full Text] [Related]
15. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922. Tolar J; Bostrom BC; La MK; Sather HN Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062 [TBL] [Abstract][Full Text] [Related]
16. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V; Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892 [TBL] [Abstract][Full Text] [Related]
18. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600 [TBL] [Abstract][Full Text] [Related]
20. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence. Wu S; Korte A; Gessner R; Henze G; Seeger K Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]